Epidemiology and cost of heart failure in children.

TitleEpidemiology and cost of heart failure in children.
Publication TypeJournal Article
Year of Publication2015
AuthorsNandi D, Rossano JW
JournalCardiol Young
Volume25
Issue8
Pagination1460-8
Date Published2015 Dec
ISSN1467-1107
KeywordsAmbulatory Care, Cardiomyopathies, Cardiomyopathy, Dilated, Cardiomyopathy, Hypertrophic, Cost of Illness, Cost-Benefit Analysis, Female, Heart Defects, Congenital, Heart Failure, Hospitalization, Humans, Infant, United States
Abstract

Heart failure in children is a complex disease process, which can occur secondary to a variety of aetiologies, including CHD, cardiomyopathy, or acquired conditions as well. Although the overall incidence of disease is low, the associated morbidity and mortality are high. Mortality may have decreased slightly over the last decade, and this is likely due to our ability to shepherd patients through longer periods of significant morbidity, with lasting effects. Costs of heart failure are significant - on the order of $1 billion annually as hospital charges for inpatient admissions alone. The value, or benefit to patient life and quality of life at this cost, is not well delineated. Further research is needed to optimise not only outcomes for these patients but also the high costs associated with them.

DOI10.1017/S1047951115002280
Alternate JournalCardiol Young
PubMed ID26675591
PubMed Central IDPMC4763311
Grant ListT32 HL007915 / HL / NHLBI NIH HHS / United States
T32-HL007915 / HL / NHLBI NIH HHS / United States